TelomEye Pharmaceuticals

Burlington, Canada

TelomEye Pharmaceuticals provides treatments to prevent and improve age-related ophthalmologic disorders.

$1.0M raised

Nov 2022

Seed

Health Care Health Diagnostics

Top Investors

RePie Asset Management Kerim Kotan Mehmet Ali Aydinlar

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TelomEye Pharmaceuticals

How much funding has TelomEye Pharmaceuticals raised?

TelomEye Pharmaceuticals has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in November 2022.

Who are TelomEye Pharmaceuticals's investors?

TelomEye Pharmaceuticals's investors include RePie Asset Management, Kerim Kotan, Mehmet Ali Aydinlar.

Where is TelomEye Pharmaceuticals headquartered?

TelomEye Pharmaceuticals is headquartered in Burlington, Canada.

What does TelomEye Pharmaceuticals do?

TelomEye Pharmaceuticals provides treatments to prevent and improve age-related ophthalmologic disorders.

What stage is TelomEye Pharmaceuticals at?

TelomEye Pharmaceuticals is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 17, 2022.

MLA

"TelomEye Pharmaceuticals — Funding & Investors." VCBacked, November 17, 2022, https://www.vcbacked.co/company/telomeye-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2022). TelomEye Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/telomeye-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=TelomEye Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/telomeye-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 17, 2022.